Figure 3.

MBS induces a weak T_H17 immune lung response. (A) Severity of the inflammatory lung response after 6.25 μg MBS exposure was measured using total broncho‐alveolar lavage (BAL) count and differential count. (B) Polarity of the effector response evaluated as number and the % of CD4⁺ cells expressing IFNg, IL‐13 or IL‐17A. (C) MBS‐specific IgG₁ and IgG_2a production was measured from serum using ELISA. Results are representative of at least three separate experiments; n = 3–6 mice/group. * = P ˂ 0.05.